AMATO, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 4.857
EU - Europa 3.335
AS - Asia 3.159
SA - Sud America 1.220
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 12.702
Nazione #
US - Stati Uniti d'America 4.757
SG - Singapore 1.217
BR - Brasile 1.081
IE - Irlanda 953
CN - Cina 857
SE - Svezia 730
HK - Hong Kong 412
IT - Italia 319
VN - Vietnam 290
DE - Germania 272
FR - Francia 218
FI - Finlandia 184
RU - Federazione Russa 150
IN - India 141
GB - Regno Unito 125
UA - Ucraina 125
PL - Polonia 93
AR - Argentina 46
CA - Canada 44
MX - Messico 36
TR - Turchia 34
BE - Belgio 32
ZA - Sudafrica 32
AT - Austria 30
JP - Giappone 30
BD - Bangladesh 24
IQ - Iraq 24
CO - Colombia 23
EC - Ecuador 21
ID - Indonesia 21
MA - Marocco 21
CI - Costa d'Avorio 18
NL - Olanda 18
CZ - Repubblica Ceca 17
ES - Italia 14
UZ - Uzbekistan 14
VE - Venezuela 13
CL - Cile 12
DZ - Algeria 12
IR - Iran 12
LT - Lituania 12
TN - Tunisia 10
AZ - Azerbaigian 9
KG - Kirghizistan 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
PK - Pakistan 8
CH - Svizzera 7
EG - Egitto 7
KE - Kenya 7
JO - Giordania 6
LB - Libano 6
PA - Panama 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
EE - Estonia 5
EU - Europa 5
PE - Perù 5
SA - Arabia Saudita 5
UY - Uruguay 5
KZ - Kazakistan 4
PS - Palestinian Territory 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
RO - Romania 3
TZ - Tanzania 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
DK - Danimarca 2
HN - Honduras 2
LV - Lettonia 2
ML - Mali 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 12.696
Città #
Dublin 951
Dallas 769
Chandler 588
Ashburn 549
Singapore 528
Hong Kong 411
Nyköping 407
Beijing 378
Jacksonville 326
Princeton 156
Medford 148
Dearborn 140
Dong Ket 132
The Dalles 131
Messina 129
Los Angeles 125
Cambridge 123
Ann Arbor 112
Des Moines 101
New York 87
Warsaw 85
Munich 83
São Paulo 67
Boardman 62
Moscow 60
Buffalo 58
Hyderabad 58
Jinan 52
Hanoi 50
Ho Chi Minh City 48
Pune 45
Bremen 44
Redondo Beach 41
Turku 40
Wilmington 39
Belo Horizonte 34
Shenyang 32
Tianjin 32
Woodbridge 32
Brussels 31
San Mateo 27
Nanjing 26
Vienna 26
Hebei 25
Helsinki 23
Rio de Janeiro 23
Johannesburg 21
Curitiba 20
London 19
Porto Alegre 19
Rome 19
Abidjan 18
Brasília 18
Campinas 18
Frankfurt am Main 18
Montreal 18
Zhengzhou 18
Catania 17
Lancaster 17
Tokyo 17
Guangzhou 16
Ningbo 16
Taizhou 16
Hangzhou 15
Nanchang 15
Seattle 15
Brooklyn 14
Chennai 14
Fuzhou 14
Atlanta 12
Düsseldorf 12
Nuremberg 12
Stockholm 12
Augusta 11
Denver 11
Salvador 11
Santa Clara 11
Sorocaba 11
Tashkent 11
Boston 10
Brno 10
Chicago 10
Fortaleza 10
Houston 10
Jiaxing 10
Kameido 10
Lauterbourg 10
Norwalk 10
Orem 10
Amsterdam 9
Baghdad 9
Baku 9
Goiânia 9
Guarulhos 9
Lynnwood 9
Manaus 9
Phoenix 9
Poplar 9
Toronto 9
Bishkek 8
Totale 8.138
Nome #
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 170
111In-Pentetreotide in neuroendocrine tumours. Comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 169
A method to evaluate the dose increase in CT with iodinated contrast medium. 168
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 163
Study of photons emission from plasma generated by fast pulsed laser 159
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 159
Applicazioni di fasci laser al settore biomedico 151
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 141
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 138
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 138
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 136
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 136
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 124
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 122
Absorbed fractions for electrons in ellipsoidal volumes 121
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 119
Can contrast media increase organ doses in CT examinations? A clinical study 117
Use of Diffusion-Weighted, Intravoxel Incoherent Motion, and Dynamic Contrast-Enhanced MR Imaging in the Assessment of Response to Radiotherapy of Lytic Bone Metastases from Breast Cancer 117
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 116
A methodological approach to a realistic evaluation of skin absorbed doses during manipulation of radioactive sources by means of GAMOS Monte Carlo simulations 115
Evaluation of absorbed fractions for beta-gamma radionuclides in ellipsoidal volumes of soft tissue through Geant4 114
Internal Dosimetry of Ellipsoidal Targets: models and applications 114
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals 114
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 113
A Monte Carlo study of small-scale dosimetry in capillary vessels during internal radionuclide therapies with 223Ra, 111In, 131I and 177Lu 112
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 112
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 111
Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice 111
Hyperthyroidism treatment with calculated activity of 131–radioiodine 105
A model for computing absorbed fractions for alpha particles in ellipsoidal volumes 104
Iodine-131 treatment of hyperthyroidism: our experience 103
A microdosimetric model of solid tumour microvasculature for radiopharmaceuticals labeled with 223 Ra, 111 In, 131 I and 177 Lu 103
Radiation field characterization and shielding studies 102
A systematic study of 64Cu production on Ni target with 11 MeV protons 101
Absorbed fractions in ellipsoidal volumes for ß- radionuclides employed in internal radiotherapy 100
Absorbed fractions for photons in ellipsoidal volumes 100
Monte Carlo study of the attenuation properties of plastic shields for beta radionuclides employed in internal radiotherapy 100
Evaluation of the dose perturbation around gold and steel fiducial markers in a medical linac through Geant4 Monte Carlo simulation. 99
A general model for internal dosimetry of electrons and photons in ellipsoidal volumes 99
Dosimetry of lesions and critical organs during 111In-Octreotide and 90Y-Dotatoc therapies of neuroendocrine tumors 98
Plastic materials as a radiation shield for ß- sources: a comparative study through Monte Carlo calculation 98
Monte Carlo simulation for design and optimization of beta-gamma shields employed in radiopharmaceutical preparations and administration to patients 98
Advances in Monte Carlo patient-specific internal dosimetry for 90 Y-TARE treatments. 97
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 97
Radiation effects on poly(methyl methacrylate) induced by pulsed laser irradiations 96
Iodine-131 treatment of hyperthyroidism: a retrospective study 96
Evaluation of absorbed doses to Autonomous Thyroid Nodules (ATN) during 131-I treatment: comparison between traditional approach and Geant4 Monte Carlo 95
Trattamento dell'ipertiroidismo con attività di radioiodio calcolata per singolo paziente (dosimetria personalizzata). 94
A general model for internal dosimetry in ellipsoidal volumes for alpha, beta and gamma emitters 94
Calibration of a gamma camera for 177Lu quantitative imaging: measurements of sensitivity and scatter correction factors in broad beam geometry 93
Absorbed fractions for alpha particles in ellipsoidal volumes 93
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 93
Study of the production yields of 18F, 11C, 13N and 15O positron emitters from plasma-laser proton sources at ELI-Beamlines for labeling of PET radiopharmaceuticals 93
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario 92
18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability 91
NEMO: Status of the project 89
GEANT4 e FLUKA nella determinazione dei fattori “S” in dosimetria interna a voxel 89
Effect of Beta Particles Spectrum on Absorbed Fraction in Internal Radiotherapy 89
Risposta di un apparato Cerenkov sottomarino a neutrini da supernova 89
X-ray emission from plasma generated by nanosecond laser irradiating tantalum 88
A systematic, theoretical study of non-carrier added 64Cu production with low energy medical cyclotrons 88
An User-Friendly Approach to the Evaluation of Skin and Eye Lens Doses to the Operators in Nuclear Medicine through Dedicated Monte Carlo Simulations in GAMOS 88
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 86
An analytical model to calculate absorbed fractions for internal dosimetry with alpha, beta and gamma emitters 86
Internal dosimetry of Ellipsoidal Targets: Models and Applcations. 84
An analytical model for calculating internal dose conversion coefficients for non-human biota 84
Monte Carlo based dose-rate assessment in 18F-Choline PET examination: a comparison between GATE and GAMOS codes 84
Valutazione dell'incremento di dose agli organi in TC a seguito di somministrazione di mezzo di contrasto iodato 83
Middle-term outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 82
Geant4 simulation of the attenuation properties of plastic shields for beta radionuclides employed in internal radiotherapy 82
Response of an Underwater Cherenkov detector to supernova neutrinos 82
90Y-AVIDIN for the brachytherapy of prostate carcinoma: a dosimetric model for a feasibility study 80
QUANTIFICAZIONE DELL' INCREMENTO DI DOSE IN TC INRAPPORTO ALLA SOMMINISTRAZIONE DI MEZZO DI CONTRASTO. 79
Evaluation of skin absorbed doses during manipulation of radioactive sources: a comparison between VARSKIN code and Monte Carlo simulations 79
Schermatura di sorgenti ß - tramite materiali plastici: uno studio comparativo tramite simulazione MonteCarlo 78
Enhancement of radiation exposure risk from β-emitter radionuclides due to Internal Bremsstrahlung effect: A Monte Carlo study of 90Y case 78
Shielding of Ionizing Radiations with PTFE 77
VANTAGGI DELLA DOSIMETRIA PERSONALIZZATA VS ATTIVITA’ STANDARD DI RADIOIODIO NELLA TERAPIA DELL’IPERTIROIDISMO: LA NOSTRA ESPERIENZA 77
Internal Dosimetry In Nuclear Medicine 77
Evaluation of the production capabilities of 18F, 11C, 13N and 15O PET isotopes at the PET-cyclotron-radiochemistry site of Messina University 76
An analytical method for computing voxel S values for electrons and photons 76
Shield design and operator's exposure extimation during nuclear medicine 90Y- and 177Lu- therapies using Monte Carlo simulations 75
The Italian multicentre dosimetric study for lesion dosimetry in 223Ra therapy of bone metastases: Calibration protocol of gamma cameras and patient eligibility criteria 75
Laser-accelerated Proton Beams from a Solid Hydrogen Target as a Future Source of Radionuclides for Positron Emission Tomography 75
HYPERTIROIDISM TREATMENT WITH CALCULATED ACTIVITY OF 131I-RADIOIODINE: OUR EXPERIENCE 74
Applications of the Monte Carlo Method in Medical Physics 73
Thyroid remnant ablation with 131I in patients affected by differentiated thyroid cancer: what is the best activity? 72
Stima di dose al tessuto circostante un fiducial in oro irradiato a 6 MV tramite simulazione in Geant4 71
Research and Development of Ion Sources 70
Full Monte Carlo internal dosimetry in nuclear medicine by means of GAMOS 70
Ions, electrons and X-rays produced by pulsed Nd:YAG laser irradiating metals 69
Study of the photon emission from plasma generated by fast pulsed laser 67
Ions, electrons and x-rays produced by pulsed nd:yag laser irradiating metals 66
Comparison of Geant4 and MCNPX Monte Carlo systems in the calculation of voxel S values for the therapeutic radionuclides 90Y, 111In, 177Lu and 131I 66
Future laser-accelerated proton beams at ELI-Beamlines as potential source of positron emitters for PET 66
Optimization of radiation shielding of 68Ga sources for positron emission tomography 66
Monte Carlo methods in nuclear medicine 66
Production of 68Ge, 64Cu, 86Y, 89Zr, 73Se, 77Br and 124I positron emitting radionuclides through future laser-accelerated proton beams at Eli-Beamlines for innovative PET diagnostics 65
Comment on: “Technical Note: Single time point dose estimate for exponential clearance” [Med. Phys. 45(5), 2318-2324 (2018)] 65
Study of the X-ray emission from Ta plasma obtained by ns laser ablation 64
Totale 9.779
Categoria #
all - tutte 50.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021482 0 0 0 0 0 64 16 32 61 64 79 166
2021/2022988 9 143 7 30 33 8 46 70 18 108 170 346
2022/20232.497 211 218 110 177 191 236 30 124 1.135 10 38 17
2023/2024717 44 106 45 78 63 169 18 21 3 75 8 87
2024/20253.136 36 41 47 188 127 99 78 653 792 215 312 548
2025/20263.317 464 580 796 664 760 53 0 0 0 0 0 0
Totale 12.965